Skip to main content
TipRanks
Go Ultimate75% OFF

Akebia Therapeutics (AX9) Q2 2026 Earnings Report

2 Followers

DE:AX9 Q2 2026 EPS Results

Actual EPS
-EUR 0.03
Consensus EPS
-EUR 0.04
Beat/Miss
Beat by +EUR 0.01
One Year Ago EPS
EUR 0.00

DE:AX9 Q2 2026 Revenue Results

Actual Revenue
EUR 44.57M
Expected Revenue
EUR 44.32M
Beat/Miss
Beat by +EUR 250.40K
YoY Revenue Growth
-21.36%

Earnings Announcement Details

Quarter
Q2 2026
Date
08/05/2026
Time
After Close
Conference Call
Wednesday, August 5, 2026
DE:AX9 Upcoming Earnings

Akebia Therapeutics's next earnings date is estimated for March 3, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

DE:AX9 Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:AX9 Earnings History

DE:AX9 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 03, 20272026 (Q4)-0.06--0.05――
Nov 05, 20262026 (Q3)-0.03-0.050―
Aug 05, 20262026 (Q2)-0.04-0.030―
May 07, 20262026 (Q1)-0.03-0.030.03-200.00% (-0.05)
Feb 26, 20262025 (Q4)-0.03-0.05-0.0950.00% (+0.05)
Nov 10, 20252025 (Q3)-0.010.00-0.09100.00% (+0.09)
Aug 07, 20252025 (Q2)-0.010.00-0.04100.00% (+0.04)
May 08, 20252025 (Q1)-0.030.03-0.08133.33% (+0.11)
Mar 13, 20252024 (Q4)-0.07-0.090―
Nov 07, 20242024 (Q3)-0.06-0.09-0.07-25.00% (-0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed